E
Anixa Biosciences, Inc. ANIX
$3.22 -$0.15-4.45% NASDAQ
Recommendation
Prev Close
$3.22
Volume
85,602
Avg Vol (90D)
108,395
Market Cap
$103.72M
Dividend & Yield
--
52-Week Range
$2.07 - $4.20
P/E (TTM)
--
EPS (TTM)
-$0.3773
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Anixa Biosciences (ANIX, $3.22) Moving Average Convergence Divergence (MACD) Histogram turned negative on July 25, 2025
7/26/2025 - Tickeron - Stocks
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?
7/25/2025 - Zacks Investment Research
Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s
7/24/2025 - GuruFocus
Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into ...
7/24/2025 - GuruFocus
Anixa Biosciences (ANIX) Secures Patent for Breast Cancer Vaccine Technology ANIX Stock News
7/24/2025 - GuruFocus
Anixa Biosciences awarded new U.S. patent for breast cancer technology
7/24/2025 - The Fly
Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s
7/24/2025 - PR Newswire
Anixa Biosciences Inc (NASDAQ:ANIX) Director Acquires $16,950.00 in Stock
7/23/2025 - Ticker Report
Anixa Biosciences (ANIX, $3.34) Aroon Indicator entered a Downtrend on July 22, 2025.
7/23/2025 - Tickeron - Stocks
Arnold M. Baskies Purchases 5,000 Shares of ANIXA BIOSCIENCES INC (NASDAQ:ANIX) Stock
7/22/2025 - MarketBeat
Anixa Biosciences (ANIX, $3.43) Aroon Indicator entered a Downtrend on July 21, 2025.
7/22/2025 - Tickeron - Stocks
Anixa Biosciences Inc (NASDAQ:ANIX) Director Purchases $16,950.00 in Stock
7/21/2025 - MarketBeat
Insider Buying: Arnold Baskies Acquires Additional Shares of Anixa Biosciences Inc (ANIX)
7/21/2025 - GuruFocus
Anixa Biosciences (ANIX, $3.44) Aroon Indicator entered a Downtrend on July 18, 2025.
7/19/2025 - Tickeron - Technical Analysis
Anixa Biosciences (ANIX, $3.44) price may drop as it broke higher Bollinger Band on Jul 18, 2025
7/19/2025 - Tickeron - Technical Analysis
Anixa Biosciences (ANIX, $3.44) Moving Average Convergence Divergence (MACD) Histogram turned positive on July 18, 2025
7/19/2025 - Tickeron - Technical Analysis
Insider Buying: Anixa Biosciences Inc (NASDAQ:ANIX) Director Acquires $31,400.00 in Stock
7/18/2025 - Ticker Report
The Math Shows DFAC Can Go To $40
7/16/2025 - ETF Channel
Anixa Biosciences (ANIX, $3.2) Stochastic Oscillator left the oversold zone on July 15, 2025
7/16/2025 - Tickeron - Stocks
Anixa Biosciences: Oncology Platform With Asymmetric Upside
7/15/2025 - Seeking Alpha - Long Ideas
Anixa Biosciences: Oncology Platform With Asymmetric Upside
7/15/2025 - SeekingAlpha
Insider Buying: Titterton Lewis H jr Acquires Additional Shares of Anixa Biosciences Inc (ANIX)
7/15/2025 - GuruFocus
Insider Buying: Anixa Biosciences Inc (NASDAQ:ANIX) Director Acquires 10,000 Shares of Stock
7/15/2025 - MarketBeat
Anixa Biosciences Inc (NASDAQ:ANIX) CEO Amit Kumar Acquires 5,000 Shares
7/15/2025 - MarketBeat
Anixa Biosciences Inc (NASDAQ:ANIX) CEO Amit Kumar Purchases 5,000 Shares
7/14/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$13.14M
Net Income (TTM)
-$12.13M
Balance Sheet
Total Assets (Q)
$16.98M
Total Debt (Q)
$221.00K
Total Liabilities (Q)
$2.07M
Book Value Per Share (Q)
$0.4988
Cash Flow
Cash from Operations (TTM)
-$7.98M
Cash from Investing (TTM)
$8.64M
Cash from Financing (TTM)
$256.00K
Net Change in Cash (TTM)
$915.00K
Filings
Filing Date
Wednesday, May 28, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Sep 1 and 5 (est)
Price History
Loading...
Beta
1.02
7-Day Total Return
-3.88%
30-Day Total Return
-10.56%
60-Day Total Return
15.41%
90-Day Total Return
5.57%
Year to Date Total Return
35.86%
1-Year Total Return
5.57%
2-Year Total Return
-9.30%
3-Year Total Return
-1.83%
5-Year Total Return
11.03%
52-week Low
Jan 14, 2025 - $2.07
52-week High
Nov 08, 2024 - $4.20
Valuation
Market Cap
$103.72M - Micro Cap
Enterprise Value
$87.18M
Price/Sales (TTM)
--
Price/Book (Q)
6.46
Dividends and Shares
Shares Outstanding
32.20
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.anixa.com
Phone Number
408 708 9808
Address
3150 Almaden Expressway
San Jose, CA 95118
Country
United States
Year Founded
1982
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a... more
NASDAQ 07/25/2025 4:00PM Eastern Quotes delayed